Novavax COVID-19 Vaccine Could Get EU Approval ‘In Weeks’

Having completed a rolling review, the vaccine is now being evaluated by the European Medicines Agency for conditional marketing authorization under an accelerated timeline.

Inspection and control of vaccines on the production line
Another COVID-19 vaccine could soon be on the way • Source: Alamy

The EU could see its fifth COVID-19 vaccine approved in a matter of weeks after the European Medicines Agency said it had begun reviewing Novavax, Inc.’s application for a conditional marketing authorization (CMA) for Nuvaxovid (also known as NVX-CoV2373).

The EMA said the evaluation would be carried out under an accelerated timeline because it had already assessed a substantial...

Welcome to Pink Sheet

Create an account to read this article

More from Europe

Spain’s Medicines Shortages Plan Clears Administrative Hurdles For Essential Medicine Manufacturers

 

A new plan to tackle medicine shortages proposes to develop a set of incentives for companies to manufacture essential medicines in Spain.

EU Industry Proposes 3-Basket Strategy To Phase Out Animal Testing

 

A “basket approach” to phasing out animal testing could help identify areas where “moonshot” research is required to implement new approach methodologies, according to EU industry federation EFPIA.

England Leads Europe In Reimbursing Vertex’s Next-In-Class CF Drug Alyftrek

 

Vertex said it reached “a broad reimbursement agreement” with the National Health Service for its once-daily, triple combination treatment for cystic fibrosis. As for reimbursement in the rest of Europe, the company is targeting Ireland, Denmark and Germany next.

UK HRA Working On ‘Trusted’ Path Forward To Support Simplified Informed Consent

 
• By 

The Health Research Authority is working on a streamlined model for informed consent that maintains people’s trust.

More from Geography